Study of LM-108 as a Single Agent or in Combination With Pembrolizumab in Subjects With Advanced Solid Tumours
Clinical trial NCT05255484 · TERMINATED
Trial details
- NCT number
- NCT05255484
- Sponsor
- LaNova Medicines Limited
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-26
- Primary completion
- 2023-10-06
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.